LUMOS PHARMA, INC. Insider Trading for April 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LUMOS PHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LUMOS PHARMA, INC. for April 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | Zoth Lota S. | Director | Option Exercise | A | 7.78 | 5,684 | 44,222 | 5,684 | |
| Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | Zoth Lota S. | Director | Grant | A | 0.00 | 709 | 0 | 1,820 | 1.1 K to 1.8 K (+63.82 %) |
| Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | Raffin Thomas A. | Director | Option Exercise | A | 7.78 | 5,684 | 44,222 | 5,684 | |
| Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | Raffin Thomas A. | Director | Grant | A | 0.00 | 709 | 0 | 7,889 | 7.2 K to 7.9 K (+9.87 %) |
| Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | McCracken Joseph S | Director | Option Exercise | A | 7.78 | 5,684 | 44,222 | 5,684 | |
| Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | McCracken Joseph S | Director | Grant | A | 0.00 | 709 | 0 | 709 | 0 to 709 |
| Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | LALANDE KEVIN M. | Director | Option Exercise | A | 7.78 | 5,684 | 44,222 | 5,684 | |
| Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | LALANDE KEVIN M. | Director | Grant | A | 0.00 | 709 | 0 | 709 | 0 to 709 |
| Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | Cunningham Emmett | Director | Option Exercise | A | 7.78 | 5,684 | 44,222 | 5,684 | |
| Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | Cunningham Emmett | Director | Grant | A | 0.00 | 709 | 0 | 709 | 0 to 709 |
| Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | JOHNSON CHAD ALLEN | Director | Option Exercise | A | 7.78 | 5,684 | 44,222 | 5,684 | |
| Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | JOHNSON CHAD ALLEN | Director | Grant | A | 0.00 | 709 | 0 | 709 | 0 to 709 |
| Apr 03 2020 | NLNK | LUMOS PHARMA, INC. | POWERS BRADLEY J | General Counsel | Option Exercise | A | 7.87 | 25,000 | 196,750 | 25,000 | |
| Apr 03 2020 | NLNK | LUMOS PHARMA, INC. | POWERS BRADLEY J | General Counsel | Grant | A | 0.00 | 4,500 | 0 | 4,555 | 55 to 4.6 K (+8,181.82 %) |
| Apr 03 2020 | NLNK | LUMOS PHARMA, INC. | McKew John C. | Chief Scientific Of ... | Option Exercise | A | 7.87 | 65,000 | 511,550 | 65,000 | |
| Apr 03 2020 | NLNK | LUMOS PHARMA, INC. | McKew John C. | Chief Scientific Of ... | Grant | A | 0.00 | 13,000 | 0 | 13,000 | 0 to 13 K |
| Apr 03 2020 | NLNK | LUMOS PHARMA, INC. | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 7.87 | 25,000 | 196,750 | 25,000 | |
| Apr 03 2020 | NLNK | LUMOS PHARMA, INC. | Lawley Lori D | Principal Accountin ... | Grant | A | 0.00 | 4,500 | 0 | 4,842 | 342 to 4.8 K (+1,315.79 %) |
| Apr 03 2020 | NLNK | LUMOS PHARMA, INC. | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 7.87 | 45,000 | 354,150 | 45,000 | |
| Apr 03 2020 | NLNK | LUMOS PHARMA, INC. | Langren Carl W. | Chief Financial Off ... | Grant | A | 0.00 | 9,000 | 0 | 11,238 | 2.2 K to 11.2 K (+402.14 %) |
| Apr 03 2020 | NLNK | LUMOS PHARMA, INC. | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 7.87 | 45,000 | 354,150 | 45,000 | |
| Apr 03 2020 | NLNK | LUMOS PHARMA, INC. | Kennedy Eugene P. | Chief Medical Offic ... | Grant | A | 0.00 | 9,000 | 0 | 10,484 | 1.5 K to 10.5 K (+606.47 %) |
| Apr 03 2020 | NLNK | LUMOS PHARMA, INC. | Hawkins Richard J | Chief Executive Off ... | Option Exercise | A | 7.87 | 135,000 | 1,062,450 | 135,000 | |
| Apr 03 2020 | NLNK | LUMOS PHARMA, INC. | Hawkins Richard J | Chief Executive Off ... | Grant | A | 0.00 | 25,000 | 0 | 744,575 | 719.6 K to 744.6 K (+3.47 %) |